Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Inks Oligo Supply Deal with RCUK

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today announced that it has signed a three-year deal to be a preferred supplier of synthetic oligonucleotides to Research Councils UK Shared Services Centre Ltd.

St. Louis-based Sigma said that it has a UK production facility in Haverhill, near Cambridge, that enables faster and more efficient delivery of products to its UK customers. Michael Harris, managing director of Europe, Middle East, and Africa for Sigma-Aldrich said that the new contract builds on its relationship with the Medical Research Council — one of the UK's seven Research Councils — as a preferred oligo supplier.

The firm's Sigma Life Sciences division offers a "range of high-quality oligonucleotide modifications, purifications, synthesis scales, and qPCR probes," the firm said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.